vincristine-induced motor peripheral neuropathy
Related entities
Findings (27)
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null
None
nullGlutamine supplementation did not produce significant improvements in motor neuropathy scores by NCI-CTCv3 clinical assessment or by serial neuropsychological battery testing at any time point post-ra
Effect: null